WO1991013638A1 - Cell culture products - Google Patents

Cell culture products Download PDF

Info

Publication number
WO1991013638A1
WO1991013638A1 PCT/GB1991/000329 GB9100329W WO9113638A1 WO 1991013638 A1 WO1991013638 A1 WO 1991013638A1 GB 9100329 W GB9100329 W GB 9100329W WO 9113638 A1 WO9113638 A1 WO 9113638A1
Authority
WO
WIPO (PCT)
Prior art keywords
film
substrate
εubεtrate
polymer
subεtrate
Prior art date
Application number
PCT/GB1991/000329
Other languages
French (fr)
Inventor
Yvonne Margaret Barlow
Stephen Michael Lang
Original Assignee
Smith & Nephew Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Plc filed Critical Smith & Nephew Plc
Priority to EP91905276A priority Critical patent/EP0518920B1/en
Priority to DE69120527T priority patent/DE69120527T2/en
Priority to AU73485/91A priority patent/AU649656B2/en
Publication of WO1991013638A1 publication Critical patent/WO1991013638A1/en
Priority to GB9205228A priority patent/GB2252562B/en
Priority to US09/009,673 priority patent/US6039972A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/34—Internal compartments or partitions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/08—Flask, bottle or test tube
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Definitions

  • This invention relates to the culturing of mammalian anchorage dependent cells onto a conformable substrate. More particularly the invention relates to the formation of wound dressings suitable for treating for example partial thickness wounds such as burns and skin graft donor sites and to systems for use in the preparation of such dressings.
  • Mammalian cells that are incapable of proliferating in suspended liquid culture but can be made to proliferate on the surface of a substrate are said to be anchorage-dependent.
  • Epithelial cells such as keratinocyte ⁇
  • keratinocyte ⁇ are anchorage dependent. Such cells cultured in the presence of a substrate which is non-inhibitory and non-cytotoxic will multiply in stratified colonies and eventually produce a confluent layer. Cell cultures of this type are used to investigate skin growth and have been used as skin grafts.
  • Various technical papers have been published which describe in vitro techniques for growing skin cells and their subsequent use in the treatment of full-thickness wounds. For example E. Bell et al (J Invest Derm 81; 2s-10 ⁇ 1983); E. Bell et al (Science 211; 1052-1054 1981); D. A ⁇ selineau and M. Pruneiras (Br J Derm 1984 III, Supplement 27, 219-222) and J.F. Burke et al (Ann Surg 94; 413-428 1981).
  • the ability of cells to anchor to a particular substrate is dependent on the properties of the substrate itself as well as the culturing conditions and the component ⁇ of the culture medium.
  • Culturing i ⁇ usually carried out in hard plastic flask ⁇ made from a material which i ⁇ substantially inert to the growth media and is non-cytotoxic to the cells.
  • Polystyrene is a commonly used material for culture flasks.
  • the sheet of cells can be supported after it has been dislodged from the surface in order to facilitate handling and transfer to the wound surface.
  • this technique does not overcome the problems associated with hard surface cultures or the risks associated with dislodge ent of the cells.
  • Epithelial cells have also been grown on natural materials such as collagen which can then be used directly as a skin replacement.
  • the technique ⁇ are described in the papers referred to hereinbefore. Whilst epithelial cells grow well on collagen there are several di ⁇ advantage ⁇ in u ⁇ ing such a material. Since collagen i ⁇ a natural substance it is not well defined and can vary substantially from one batch to another which i ⁇ clinically undesirable if it i ⁇ to be u ⁇ ed a ⁇ a ⁇ kin graft. Collagen is also a difficult material to work with in the laboratory and it is a complex and time consuming process to isolate it, making it expensive to produce.
  • a conformable wound dre ⁇ ing comprising a layer of cultured mammalian cells anchored to one ⁇ urface of a sub ⁇ trate comprising a film of synthetic polymer and which substrate is hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
  • the present invention also provides a system for the manufacture of wound dressings comprising a substrate for culturing anchorage dependent mammalian cells and means for maintaining a culture medium in contact with said substrate wherein said sub ⁇ trate is a conformable film of a synthetic polymeric material which is hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
  • the present invention further provides a method for producing a wound dressing by culturing anchorage dependent mammalian cells onto a substrate contained within the ⁇ y ⁇ tem.
  • the mammalian cell ⁇ employed in the pre ⁇ ent invention are those cell ⁇ which are anchorage-dependent i.e. they require a sub ⁇ trate onto which they can bind before they are able to proliferate.
  • the sub ⁇ trate should preferably be a corona-di ⁇ charge treated film.
  • Corona di ⁇ charge treatment increases the surface energy of a material and provides improved conditions for cell anchorage.
  • the effect of corona-discharge treatment can be asse ⁇ ed by measuring the contact angle of water on the treated material. A method for measuring contact angle will be hereinafter described. Aptly the contact angle should be reduced by at least 10%, favourably by at least 15% and preferably by at least 20%.
  • the substrate is a conformable synthetic polymeric film.
  • the substrate In order for the sub ⁇ trate to have the - 7 - flexibility and conformability required for the purposes of the present invention it ⁇ hould ⁇ uitably have a thickne ⁇ not exceeding 0.075mm. More ⁇ uitably the substrate will have a thickness not exceeding 0.05mm, and favourably not exceeding 0.04mm. More favourably the substrate will have a thicknes ⁇ between 0.005mm - 0.03mm and preferably between 0.010mm and 0.025mm for example, 0.015mm or 0.020mm.
  • the substrate is formed from a hydrophobic material.
  • 'hydrophobic' i ⁇ meant that the water-uptake does not exceed 15% by weight of the material. More aptly the water uptake should not exceed 10% and favourably it should not exceed 7% by weight of the material. More favourably the water uptake of the substrate should not exceed 5% by weight of the material.
  • the ⁇ ub ⁇ trate should not ⁇ well at all when in contact with aqueous media.
  • Percentage water uptake of the substrate i ⁇ a ⁇ e ⁇ sed by the following method A 5 cm x 5 cm piece of the substrate is weighed in its dry ⁇ tate. Thi ⁇ i ⁇ then immersed in exce ⁇ distilled water (at least 100 mis) and left for a period of 24 hours at 20 C. The piece of the substrate is then removed, excess water is allowed to drain and the substrate is re-weighed. The percentage increase in weight obtained is the percentage water uptake.
  • the sub ⁇ trate should not be inhibitory to cell growth.
  • a measure of such inhibition can be expres ⁇ ed a ⁇ a percentage cell growth reduction a ⁇ mea ⁇ ured against cells allowed to grow in the absence of a test ⁇ ub ⁇ trate a ⁇ hereinafter described.
  • the ⁇ ub ⁇ trate ⁇ hould not re ⁇ ult in more than 50% reduction in cell growth. More aptly it ⁇ hould not re ⁇ ult in more than a 40% reduction in cell growth.
  • the sub ⁇ trate ⁇ hould not be cytotoxic to cell growth. Cytotoxicity can be mea ⁇ ured again ⁇ t a non-cytotoxic control material by a method a ⁇ hereinafter described. Aptly the cytoxicity of the substrate will not exceed 30%. More aptly the cytotoxicity of the sub ⁇ trate will not exceed 20%. Favourably the cytotoxicity of the sub ⁇ trate will not exceed 20% and preferably it will not exceed 15%.
  • the sub ⁇ trate may be in the form of a continuou ⁇ film or an apertured film, for example, formed into a net.
  • the substrate is a continuous film which is adapted to be perforated after the cell layer has formed on the sub ⁇ trate.
  • apertured dres ⁇ ing ⁇ in accordance with the invention ha ⁇ the advantage that wound exudate, found in a wound covered by a dre ⁇ ing of the invention, can readily escape through the apertures and not build up under the dre ⁇ ing ⁇ .
  • Perforation of the film can be carried out by any suitable conventional method such as hot pin perforation or slitting.
  • Perforation after cell growth should be carried with minimum cell disruption and loss.
  • Aptly perforation should give at least a 5% open area and preferably at least 20% open area.
  • Aptly perforation should give les ⁇ than 50% open area and preferably less than 40% open area. 25% open area i ⁇ an example.
  • An especially preferred form of substrate which is adapted to be perforated after cell culture is a continuous film which has been biaxially orientated, for example by drawing and stretching in the machine or transver ⁇ e direction during manufacture such that when the films are subsequently stretched in the other direction, aperatures are formed therein.
  • films are described, for example, in UK-914489, UK-1055963, EP-0141592.
  • the film ⁇ forming the substrate may be flat or contoured, for example by embossing.
  • contoured film ⁇ may also have apertures.
  • Such contoured materials are described in WO90/00398, for u ⁇ e as cove'r ⁇ tock ⁇ .
  • the continuou ⁇ film ⁇ comprising the sub ⁇ trate ⁇ hould be permeable to moisture vapour, oxygen and carbon dioxide.
  • MVTR moisture vapour transmission rate
  • the ⁇ ub ⁇ trate ⁇ hould have an MVTR not exceeding 1500gm -2 24 hr ⁇ -1.
  • _2 ⁇ ub ⁇ trate ⁇ hould have an MVTR not exceeding 1200gm 24 hr ⁇ and preferably not exceeding lOOOgm " 24 hrs .
  • the moisture vapour transmi ⁇ ion rate may be mea ⁇ ured by the Payne Cup method.
  • Thi ⁇ method uses a cup 1.5cm deep which has a flanged top.
  • the ⁇ ub ⁇ trate could be formed from knitted or woven polymers to form a tight web of ⁇ mall mesh ⁇ ize. After cell culture the web centre can be stretched to form a web having a larger mesh size without loss of cell ⁇ .
  • the sub ⁇ trate could comprise two interlocking nets such that the aperture ⁇ in one net correspond to the strand portions of the other net.
  • the two net ⁇ could then be peeled apart po ⁇ t-culture and since both would carry cells they could both be applied to the patient.
  • Suitable corona-discharge treated polymeric film ⁇ may have a thickne ⁇ not exceeding 0.075mm, a water uptake not exceeding 15%, a percentage reduction in cell growth of not more than 50%, a cytotoxicity of not more than 30% and a moisture vapour permeability not exceeding 2500gm -2 24hr ⁇ -1
  • the polymer ⁇ employed in the pre ⁇ ent invention are ⁇ ynthetic and do not comprise any naturally occuring polymeric materials or residues. Such synthetic polymer ⁇ can therefore be produced to a high degree of conformity and con ⁇ i ⁇ tency.
  • Suitable polymer ⁇ having for u ⁇ e in the manufacture of the ⁇ ubstrates employed in the dressings of invention include copolymer ⁇ , block copoly ers and polymer blends.
  • Apt copolymer ⁇ are tho ⁇ e containing vinyl acetate re ⁇ idue ⁇ such a ⁇ the ethylene-vinyl acetate copolymer ⁇ .
  • Suitable ethylene-vinyl acetate copolymer ⁇ are those containing not more than 20% vinyl acetate.
  • a preferred material, known a ⁇ EVA 538/539 contain ⁇ 16% vinyl acetate.
  • ⁇ uitable polymer ⁇ include essentially hydrocarbon based materials such as the polybutadienes, polypropylene and polystyrene.
  • Preferred grades of polystyrene include the high impact polystyrenes such as that sold under the trade name STYRON.
  • Suitable polymer ⁇ for u ⁇ e in the invention may include block copolymer ⁇ having hard end blocks and softer mid blocks.
  • Apt block copolymer ⁇ include styrene based rubbers such a ⁇ ⁇ tyrene-butadiene- ⁇ tyrene (manufactured by Shell Chemical Co under the trade name CARIFLEX or KRATO ) .
  • Another cla ⁇ s of polymers suitable for the purposes of the invention are polye ⁇ ter ⁇ .
  • Polymer blend ⁇ may al ⁇ o be employed for the ⁇ ub ⁇ trate ⁇ of the invention.
  • Preferred material ⁇ are blends of ethylene-vinyl acetate with hydrocarbons such a ⁇ a polyolefin or an aromatic hydrocarbon.
  • a preferred material i ⁇ a blend of 90% EVA and 10% high impact poly ⁇ tyrene.
  • the polymeric film sub ⁇ trate should desirably be transparent in order to allow visualisation of the wound through the dres ⁇ ing.
  • the cells are keratinocyte ⁇ .
  • the cells are keratinocyte ⁇ .
  • the cell ⁇ ⁇ hould have reached at lea ⁇ t 30% confluence before tran ⁇ fer, favourably at lea ⁇ t 40% and preferably at lea ⁇ t 50%.
  • a ⁇ uitable wound dressing could be produced within a few hours making the dressing particularly suitable for use as an emergency field dre ⁇ ing when rapid treatment is required.
  • the dres ⁇ ing compri ⁇ e ⁇ a cell layer which i ⁇ not more than 2 cells thick, more preferably the cell layer i ⁇ a monolayer.
  • the polymeric film substrates can be ⁇ terili ⁇ ed by either ethylene oxide (allowing the required time for de-ga ⁇ ing) or by gamma-irradiation. It i ⁇ important that the polymeric film ⁇ are wa ⁇ hed to remove any low molecular weight contaminants, for example unpolymerised monomer. Such monomers can be cytotoxic and for the reasons given above the substrate should be sub ⁇ tantially non-cytotoxic.
  • the wa ⁇ hing proce ⁇ may comprise several sequential washes using sterile de-ionised water in sequential ⁇ tep ⁇ .
  • the substrate on which the cell ⁇ are grown ⁇ hould preferably be easily removable from the other parts of the system, namely the means for maintaining the aqueous culture medium containing said cell ⁇ in contact with one ⁇ urface of the film.
  • the ⁇ ub ⁇ trate forms one of the walls of the vessel containing the culture medium, it should be readily removable from the other parts of the vessel.
  • the polymeric film substrate may form a part or all of the container in which the cell culture i ⁇ grown.
  • the other part ⁇ of the container or culture ve ⁇ sel may be formed from suitable materials conventionally used for the manufacture of ti ⁇ ue culture ve ⁇ el ⁇ . High impact polystyrene is preferred.
  • the ⁇ ub ⁇ trate may be laid down within a flask of an appropriate design adapted to allow the removal of the sub ⁇ trate.
  • the ⁇ ub ⁇ trate is an integral part of the culture flask it may be removably sealed to the other parts of the flask for example by heat sealing or by mean ⁇ of an adhesive.
  • the sub ⁇ trate will form a flat ⁇ urface and will aptly form the wall of the flask.
  • the flask will be provided with a closeable opening having dimensions sufficient to enable the sub ⁇ trate to be readily removed without disruption of the cells anchored thereto.
  • apertured ⁇ ub ⁇ trate ⁇ which are used to form an integral part of the culture flask these may be overlain by continuous film to keep the vessel water tight and to maintain sterility. If the substrate is laid down within the flask or vessel it may be retained by, for example, a pre-sterilised stainless steel ring or, alternatively, by coating the sub ⁇ trate on one ⁇ ide - 17 - with a layer of non-cytotoxic adhe ⁇ ive which i ⁇ capable of maintaining tack in the presence of tissue culture medium.
  • Nutrients, growth factors or medicaments such as antibiotics or antiflammatories may be incorporated into the aqueous medium in which the cell culture i ⁇ grown.
  • the nature and weight and/or volume of such additional ingredients are conventionally well known.
  • the wound dressing of this invention is particularly suitable for treating partial-thickness wounds that i ⁇ tho ⁇ e where only the epidermi ⁇ and po ⁇ ibly part of the dermis is lo ⁇ t.
  • wounds include for example skin graft donor site ⁇ , first or pos ⁇ ibly second degree burns, shallow leg ulcers or pressure sores.
  • Continuous polymeric film sub ⁇ trate aptly act a ⁇ barrier ⁇ to bacteria whilst being sufficiently permeable to moi ⁇ ture vapour, oxygen and carbon dioxide to allow wound healing to occur at a desirable rate. If the ⁇ ub ⁇ trate i ⁇ perforated, a ⁇ econdary dressing could be applied to maintain the desired degrees of moisture vapour, oxygen and carbon dioxide permeabilities.
  • a suitable material is a polyurethane film dressing such as a ⁇ OPSITE (Trade Mark) to create the ⁇ ame condition ⁇ .
  • the dressing can suitably be left in place on the wound for a period of up to 7 days allow the wound to become from 30-90% re-epitheliali ⁇ ed (healed) depending on the nature of the particular wound and the condition of the patient. At thi ⁇ time the dre ⁇ ing can be removed and replaced with conventional wound dressings.
  • the dres ⁇ ing ⁇ of the pre ⁇ ent invention offer many advantage ⁇ ovr prior art arrangement ⁇ . Hitherto it ha ⁇ been nece ⁇ ary to culture the layer ⁇ to a thickne ⁇ of ⁇ everal cell ⁇ in order for the cell layer to be handled and manipulated. It wa ⁇ al ⁇ o nece ⁇ ary to grow cell layer ⁇ to a larger area than required for the dres ⁇ ing since during the conventional enzymatic harvesting techniques the sheet tended to shrink. In addition to the time required to produce a cell ⁇ heet which wa ⁇ both large enough to cover the wound and ⁇ trong enough to be handled, there are additional di ⁇ advantages to the use of multi-layer cell sheets.
  • the ba ⁇ al ⁇ urface (which contains actively growing cells) of the cell sheet be in contact with the wound surface.
  • the non-basal layer (where the cells are terminally differentiated) it is possible for the non-basal layer (where the cells are terminally differentiated) to be the surface in contact with the wound.
  • the dressings of the present invention which comprise a sub-confluent monolayer of cells can be readily produced in a matter of hours, can be readily handled and when presented to the wound will bring actively growing basal cells directly into contact with the host (patient) substrate.
  • system ⁇ of the invention may utilise cell feed techniques without the disadvantages hitherto associated with these techniques.
  • the feeder cells such as 3T3 may be ⁇ eeded into a medium in contact with the reverse side of the substrate. These cell ⁇ will then ⁇ ynthe ⁇ ize material ⁇ for the host cells. Since the feeder cells do not come into contact with the host cells there i ⁇ no need to irradiate them. When the ⁇ ub ⁇ trate is removed from the culture fal ⁇ k the reverse side may be washed to reverse the free floating feeder cells.
  • the aperture ⁇ ⁇ hould be large enough to allow free exchange of the culture media but not large enough to allow cell ⁇ to pa ⁇ s through.
  • the aperture size should not be larger than S ⁇ acro ⁇ it ⁇ largest dimenions.
  • the aperture ⁇ ize will be from 0.5 - 2 ⁇ .
  • one wall of a culture flask 1 comprise ⁇ a laminate of an apertured film 2 upon a confcinuou ⁇ carrier layer 3.
  • the edge ⁇ of the carrier layer are removably bonded to the other wall portions 5 of the flask 3.
  • Culture media 4 and donor cell ⁇ can be introduced into flask 3 through neck 6 and sealed therein by stopper 7.
  • the laminate 2, 3 can be removed by peeling from flask 1.
  • An apertured dre ⁇ ing compri ⁇ ing cell ⁇ anchored to ⁇ heet 2 can be separated from the carrier layer 3 and applied to a patient.
  • the laminate 2, 3 is formed by casting the ⁇ ub ⁇ trate film 2 over a carrier layer 3 being a plurality of rai ⁇ ed portions 8.
  • the cast substrate layer 2 has a plurality of thin 9 and thickened 10 areas. When the substrate is separated from the carrier layer, the thin area ⁇ 9 rupture to form aperture ⁇ 12 a ⁇ shown in Figure 3.
  • the culture fla ⁇ k 1 i ⁇ divided into compartments 21, 31 by a perforated film 2 comprising the substrate.
  • Nutrient media 4 is introduced into the flask and occupies both compartments 21, 31.
  • Skin cells are ⁇ eeded into compartment 21 through neck 6 whil ⁇ t feeder cell ⁇ ⁇ uch a ⁇ 3T3 cells are seeded into compartment 31 through access port 11.
  • Nutrients, growth factors or medicaments ⁇ uch a ⁇ antibiotic ⁇ or antiinfla matorie ⁇ may be incorporated into the aqueous medium in which the cell culture is grown.
  • the nature of weight and/or volume of ⁇ uch additional ingredient ⁇ are conventionally well known.
  • the two contact solutions used are distilled water, dekalin and glycerol.
  • the micrometer screw syringe is filled with distilled water and one drop is allowed to contact the film surface to be measured.
  • a photograph of the droplet shape is taken via a camera mounted to the eyepiece of the goniometer. Further photographs are taken periodically (every minute) for approximately ten minutes. The procedure i ⁇ then repeated u ⁇ ing glycerol and dekalin a ⁇ the contacting medium.
  • the re ⁇ ultant photographs are then developed.
  • the angle the droplet makes to the horizontal is then mea ⁇ ured u ⁇ ing a protractor (mea ⁇ ured both sides).
  • keratinocytes Human epithelial cells (keratinocytes) are seeded onto a substrate or tis ⁇ ue culture plate at a density of 8 x
  • the results are expressed as a percentage reduction in tritiated thymidine uptake compared to values obtained in control wells containing no sub ⁇ trate.
  • Each substrate is ⁇ et up in duplicate in a 6 well culture plate containing 5ml ⁇ of either ⁇ erum free media or media containing 10% foetal calf ⁇ erum. After one week' ⁇ incubation at 37°C the "substrate supernatants" are collected and frozen at -20°C until required.
  • Human epithelial cell ⁇ are ⁇ eeded at a density of 2 x
  • keratinocyte ⁇ Human Epithelial cell ⁇ (keratinocyte ⁇ ) were cultured to 50% confluence onto corona-di ⁇ charge treated disc ⁇ of 15 cm x 12 cm MELINEX film 23 / / thick.
  • Corona di ⁇ charge wa ⁇ carried out on the film substrate prior to culture using a Sherman C-treater.
  • the C-treater wa ⁇ used manually and set to deliver greater than 50 dynes/cm to the ⁇ ub ⁇ trate surface.
  • the sub ⁇ trate i ⁇ placed under the head of the machine and removed slowly in order to achieve this level of treatment.
  • Alternative but equally acceptable media include Keratinocyte Basal Media available from Clonetics & BIORICH Media available from Flow Laboratories. Both of these media are ⁇ erum free.
  • the percentage cell growth reduction was found to be 28%.
  • the percentage cellular cytotoxicity was found to be 7%.
  • Example 1 wa ⁇ repeated u ⁇ ing corona-discharge treated ethyl vinyl acetate film at 15// thickne ⁇ (EVA 538/539).
  • the percentage cell growth reduction was found to be 41.5%.
  • the percentage cellular cytotoxicity was found to be 0%.
  • the contact angle wa ⁇ found to be 78° on untreated film and 55.5° on corona-di ⁇ charge treated film.
  • Example 1 wa ⁇ repeated u ⁇ ing corona-di ⁇ charge treated polyi ⁇ obutadiene film at 20// thicknes ⁇ .
  • the percentage cell growth reduction was found to be 33%.
  • the percentage cellular cytotoxicity was found to be 1%.
  • the contact angle was found to be 98° on untreated film and 79.5% on corona-di ⁇ charge treated film.
  • Example 1 wa ⁇ repeated using corona-di ⁇ charge treated ethyl vinyl acetate/high impact poly ⁇ tyrene blends at 20 / thicknes ⁇ .
  • the following blend ⁇ gave the re ⁇ ult ⁇ ⁇ hown.
  • Example 1 was repeated u ⁇ ing corona-discharge treated polypropylene film at 20 / / thickne ⁇ .
  • the percentage cell growth reduction wa ⁇ found to be 47%.
  • the percentage cellular cytotoxicity was found to be 8%.
  • Example 1 was repeated u ⁇ ing corona-discharge treated high impact poly ⁇ tyrene film (STYRON) at 20// thickne ⁇ .
  • STYRON high impact poly ⁇ tyrene film
  • the percentage cell growth reduction was found to be 32%.
  • the percentage cellular cytotoxicity was found to be 8% .
  • Example 1 was repeated using corona-discharge treated styrene-butadiene-styrene rubber film (CARIFLEX 1101) at 20 / / thicknes ⁇ .
  • CARIFLEX 1101 corona-discharge treated styrene-butadiene-styrene rubber film
  • the percentage cell growth reduction wa ⁇ found to be 41.5%.
  • the percentage cellular cytotoxicity wa ⁇ found to be 1%.
  • Example 1 wa ⁇ repeated using corona-discharge treated polyvinylidene chloride (PVDC) film at 20// thickne ⁇ .
  • PVDC polyvinylidene chloride
  • the percentage cell growth reduction wa ⁇ found to be 27%.
  • Example ⁇ 1 - 8 were repeated but the film ⁇ were perforated prior to culture u ⁇ ing hot-pin perforation technique ⁇ to give an open area of 25%. Good cell growth wa ⁇ achieved in all ca ⁇ e ⁇ with minimal cell loss or perforation.
  • a system according to Figure 1 wa ⁇ u ⁇ ed to produce a wound dres ⁇ ing.
  • the pre-perforated films used were tho ⁇ e a ⁇ de ⁇ cribed in Example ⁇ 9 - 16.
  • the cells were grown to 20% confluence (approximately 24-36 hour ⁇ ).
  • the carrier (2) and perforated substrate carrying the cells (1) was detached from the culture ves ⁇ el (3) and the ⁇ ub ⁇ trate wa ⁇ then peeled from the carrier. Good cell growth wa ⁇ achieved in all ca ⁇ es.
  • Example ⁇ 17 - 24 were repeated but instead of pre-perforating the films they were cast onto the base of a fla ⁇ k containing 1mm stumps according to Figure 2, After culture the substrate was peeled from the base according to Figure 3 and was successfully perforated a ⁇ well a ⁇ achieving good cell growth in all ca ⁇ e ⁇ . Cell lo ⁇ wa ⁇ minimal.
  • Good cell growth wa ⁇ achieved with no lo ⁇ of cell ⁇ upon perforation.
  • Example 20 wa ⁇ repeated but the ⁇ ub ⁇ trate wa ⁇ not pre-perforated. In ⁇ tead it wa ⁇ ⁇ tretched according to Example 33 and ⁇ pontaneou ⁇ ly perforated. Good cell growth wa ⁇ achieved with no loss of cell ⁇ upon perforation.
  • a ⁇ y ⁇ tem according to Figure 1 wa ⁇ u ⁇ ed to produce a wound dre ⁇ ing.
  • the net used was as described in PCT Publication No GB090/00398.
  • the cells were grown for approximately 24 hours and the carrier (3) and net (2) carrying the cells were detached from the culture ves ⁇ el (5).
  • the net was then peeled from the carrier and good cell growth was observed on the net.
  • Example 35 wa ⁇ repeated but two sheets of the net were aligned such that the aperture ⁇ of one net coincided with the continuou ⁇ portions of the other net. The whole wa ⁇ then sealed to the bottom of the culture ve ⁇ el (5) and the cell ⁇ cultured a ⁇ before. Upon removal from the ve ⁇ el after 24 hour ⁇ the two net ⁇ were ⁇ eparated and both ⁇ howed good cell growth. Both net ⁇ were then tran ⁇ ferred to a patient succe ⁇ fully. Good heating rate ⁇ and goods host compatibility were observed.
  • Example ⁇ 1 and 2 were repeated and the resultant dres ⁇ ing ⁇ were u ⁇ ed ⁇ imultaneou ⁇ ly in the treatment of a 3 year old female burn ⁇ patient.
  • the patient wa ⁇ burned to approximately 40% of body surface area covering the head, one arm, one leg and one ⁇ ide of her body.
  • the patient wa ⁇ grafted on four separate occa ⁇ ions using a combination of split skin grafting and the wound dressing containing the culture cells.
  • the cell culture was derived from an autologous biopsy taken during debridement of the burns patient.
  • the initial seeding den ⁇ ity wa ⁇ between 2.5 x 10 and 6 x 104 cells per cm2.
  • the culture wa ⁇ grafted approximately 80 hour ⁇ after the cell ⁇ were ⁇ eeded.
  • the ⁇ ub ⁇ trate film wa ⁇ covered with a secondary dres ⁇ ing comprising a liquid paraffin tulle gras

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Clinical Laboratory Science (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

A conformable wound dressing is described which comprises a layer of cultured mammalian cells anchored to one surface of a substrate comprising a film of synthetic polymer of which substrate is hydrophobic, non-inhibiting to cell growth and non-cytotoxic. Also described is a system for the manufacture of wound dressings which system comprises a substrate for culturing anchorage dependent mammalian cells and means for monitoring a culture medium in contact with said substrate wherein said substrate is a conformable film of a synthetic polymeric material which is hydrophobic, non-inhibiting to cell growth and non-cytotoxic. Various alternative embodiments of the wound dressing and the system are described. A method for treating wounds using the dressing or system of the invention together with a method for the in vitro cultivation of anchorage dependent mammalian cells are also described.

Description

CELL CULTURE PRODUCTS
This invention relates to the culturing of mammalian anchorage dependent cells onto a conformable substrate. More particularly the invention relates to the formation of wound dressings suitable for treating for example partial thickness wounds such as burns and skin graft donor sites and to systems for use in the preparation of such dressings.
Mammalian cells that are incapable of proliferating in suspended liquid culture but can be made to proliferate on the surface of a substrate are said to be anchorage-dependent.
Epithelial cells, such as keratinocyteε, are anchorage dependent. Such cells cultured in the presence of a substrate which is non-inhibitory and non-cytotoxic will multiply in stratified colonies and eventually produce a confluent layer. Cell cultures of this type are used to investigate skin growth and have been used as skin grafts. Various technical papers have been published which describe in vitro techniques for growing skin cells and their subsequent use in the treatment of full-thickness wounds. For example E. Bell et al (J Invest Derm 81; 2s-10ε 1983); E. Bell et al (Science 211; 1052-1054 1981); D. Aεselineau and M. Pruneiras (Br J Derm 1984 III, Supplement 27, 219-222) and J.F. Burke et al (Ann Surg 94; 413-428 1981).
The ability of cells to anchor to a particular substrate is dependent on the properties of the substrate itself as well as the culturing conditions and the componentε of the culture medium. Culturing iε usually carried out in hard plastic flaskε made from a material which iε substantially inert to the growth media and is non-cytotoxic to the cells. Polystyrene is a commonly used material for culture flasks.
One of the problems in using hard plastic flasks for the culture of epithelial cells for use as skin grafts iε that the sheet of cells normally has to reach confluence before they can be harvested. The time taken to reach confluence may be long. Furthermore the layer of cells iε not very strong mechanically and can easily be damaged when the unsupported cells are dislodged and handled unsupported.
It is known that the sheet of cells can be supported after it has been dislodged from the surface in order to facilitate handling and transfer to the wound surface. However this technique does not overcome the problems associated with hard surface cultures or the risks associated with dislodge ent of the cells.
Epithelial cells have also been grown on natural materials such as collagen which can then be used directly as a skin replacement. The techniqueε are described in the papers referred to hereinbefore. Whilst epithelial cells grow well on collagen there are several diεadvantageε in uεing such a material. Since collagen iε a natural substance it is not well defined and can vary substantially from one batch to another which iε clinically undesirable if it iε to be uεed aε a εkin graft. Collagen is also a difficult material to work with in the laboratory and it is a complex and time consuming process to isolate it, making it expensive to produce. A further disadvantage iε that becauεe collagen iε a protein it cannot be eaεily εteriliεed by methods εuch aε steam penetration as it will be denatured. Accordingly it is difficult to store and to keep sterile.
In an attempt to overcome the problems associated with the use of collagen and hard plastic surfaces as cell culture subεtrates it has been proposed to grow cells on the surface of water-swellable hydrophilic synthetic polymers. The cells are not immersed in the aqueous medium but are grown at the εubstrate-gaseouε interface. The reεultant εheet is relatively bulky making it poorly conformable and the cell layer haε to be fully confluent before it can be tranεferred to the wound site which can take a considerable time for example 14-21 days. Such a procesε iε deεcribed in PCT Publication No WO88/08448.
We have now found it is possible to grow cells on a readily manageable, flexible, conformable subεtrate wherein the cells are immersed in an aqueous medium and thus avoid the problems aεsociated with cultures grown at the subεtrate - gaseous interface. Moreover, unlike the prior proposalε, it is possible and desirable to transfer a cell layer before it haε reached confluence. Moreover still this procesε iε conεiderably faεter than prior proposals taking less than 7 days to reach the transferable stage. Such a dressing therefore offers considerable advantages over the prior art.
It is an object of the invention to provide a wound dresεing which compriεeε a layer of cultured mammalian cells anchored to one surface of a conformable subεtrate which εubεtrate is a synthetic, polymeric film and which is hydrophobic, non-inhibitory to cell growth, non-cytotoxic. It is also an object of the invention to provide a system for producing a wound dressing by culturing anchorage dependent mammalian cells comprising a conformable synthetic polymeric film which is hydrophobic, non-inhibitory to cell growth, non-cytotoxic, together with a meanε for maintaining an aqueouε culture mechaniεm containing εaid cells in contact with one surface of said film.
In accordance with the preεent invention there iε provided a conformable wound dreεεing comprising a layer of cultured mammalian cells anchored to one εurface of a subεtrate comprising a film of synthetic polymer and which substrate is hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
The present invention also provides a system for the manufacture of wound dressings comprising a substrate for culturing anchorage dependent mammalian cells and means for maintaining a culture medium in contact with said substrate wherein said subεtrate is a conformable film of a synthetic polymeric material which is hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
The present invention further provides a method for producing a wound dressing by culturing anchorage dependent mammalian cells onto a substrate contained within the εyεtem.
The mammalian cellε employed in the preεent invention are those cellε which are anchorage-dependent i.e. they require a subεtrate onto which they can bind before they are able to proliferate.
By the term 'conformable' we mean that the dreεεing will conform to changeε in dimenεionε of the body portion to which the dreεεing iε attached.
In order for the εubεtrate to have deεirable εurface propertieε which allows the anchorage of the cells the subεtrate should preferably be a corona-diεcharge treated film. Corona diεcharge treatment increases the surface energy of a material and provides improved conditions for cell anchorage. The effect of corona-discharge treatment can be asseεεed by measuring the contact angle of water on the treated material. A method for measuring contact angle will be hereinafter described. Aptly the contact angle should be reduced by at least 10%, favourably by at least 15% and preferably by at least 20%.
The substrate is a conformable synthetic polymeric film. In order for the subεtrate to have the - 7 - flexibility and conformability required for the purposes of the present invention it εhould εuitably have a thickneεε not exceeding 0.075mm. More εuitably the substrate will have a thickness not exceeding 0.05mm, and favourably not exceeding 0.04mm. More favourably the substrate will have a thicknesε between 0.005mm - 0.03mm and preferably between 0.010mm and 0.025mm for example, 0.015mm or 0.020mm.
The substrate is formed from a hydrophobic material. By 'hydrophobic' iε meant that the water-uptake does not exceed 15% by weight of the material. More aptly the water uptake should not exceed 10% and favourably it should not exceed 7% by weight of the material. More favourably the water uptake of the substrate should not exceed 5% by weight of the material. Preferably the εubεtrate should not εwell at all when in contact with aqueous media.
Percentage water uptake of the substrate iε aεεeεsed by the following method. A 5 cm x 5 cm piece of the substrate is weighed in its dry εtate. Thiε iε then immersed in exceεε distilled water (at least 100 mis) and left for a period of 24 hours at 20 C. The piece of the substrate is then removed, excess water is allowed to drain and the substrate is re-weighed. The percentage increase in weight obtained is the percentage water uptake.
The subεtrate should not be inhibitory to cell growth. A measure of such inhibition can be expresεed aε a percentage cell growth reduction aε meaεured against cells allowed to grow in the absence of a test εubεtrate aε hereinafter described. Aptly the εubεtrate εhould not reεult in more than 50% reduction in cell growth. More aptly it εhould not reεult in more than a 40% reduction in cell growth. Favourably it should not result in more than a 30% reduction in cell growth and preferably not reεult in more than a 20% reduction in cell growth.
The subεtrate εhould not be cytotoxic to cell growth. Cytotoxicity can be meaεured againεt a non-cytotoxic control material by a method aε hereinafter described. Aptly the cytoxicity of the substrate will not exceed 30%. More aptly the cytotoxicity of the subεtrate will not exceed 20%. Favourably the cytotoxicity of the subεtrate will not exceed 20% and preferably it will not exceed 15%.
The subεtrate may be in the form of a continuouε film or an apertured film, for example, formed into a net. Preferably however the substrate is a continuous film which is adapted to be perforated after the cell layer has formed on the subεtrate.
The use of apertured dresεingε in accordance with the invention haε the advantage that wound exudate, found in a wound covered by a dreεεing of the invention, can readily escape through the apertures and not build up under the dreεεingε.
Perforation of the film, either before or after cell culture can be carried out by any suitable conventional method such as hot pin perforation or slitting. Perforation after cell growth should be carried with minimum cell disruption and loss. Aptly perforation should give at least a 5% open area and preferably at least 20% open area. Aptly perforation should give lesε than 50% open area and preferably less than 40% open area. 25% open area iε an example.
An especially preferred form of substrate which is adapted to be perforated after cell culture is a continuous film which has been biaxially orientated, for example by drawing and stretching in the machine or transverεe direction during manufacture such that when the films are subsequently stretched in the other direction, aperatures are formed therein. Such films are described, for example, in UK-914489, UK-1055963, EP-0141592. The filmε forming the substrate may be flat or contoured, for example by embossing. Suitably contoured filmε may also have apertures. Such contoured materials are described in WO90/00398, for uεe as cove'rεtockε.
Aptly the continuouε filmε comprising the subεtrate εhould be permeable to moisture vapour, oxygen and carbon dioxide. In this way a dresεing when in place on the wound will provide moiεt conditions allowing for the cellε to remain viable while the wound healε. The continuous films substrate, whilst desirably being impervious to liquid water may have a moisture vapour transmission rate (MVTR) not exceeding 2500 gm
24 hrs~ . More aptly the εubεtrate εhould have an MVTR not exceeding 1500gm -2 24 hrε-1. Favourably the
_2 εubεtrate εhould have an MVTR not exceeding 1200gm 24 hrε~ and preferably not exceeding lOOOgm" 24 hrs .
A method for determining the MVTR of a subεtrate iε given as follows:
The moisture vapour transmiεεion rate (MVTR) may be meaεured by the Payne Cup method. Thiε method uses a cup 1.5cm deep which has a flanged top. The inner
2 diameter of the flange provides an area of 10cm of material through which moisture vapour may pasε. In thiε method 10ml of distilled water is added to the cup and a sample of the material under test, large enough to completely cover the flange, is clamped over the cup. When the test material has an adhesive surface it is clamped with the adhesive surface facing into the cup. The complete assembly is then weighed and placed in a fan assisted electric oven where the temperature and relative humidity are maintained at 37 C and 10% respectively. The relative humidity within the over is maintained at 10% by placing 1kg of anhydrous 3-8 mesh calcium chloride on the floor of the oven. After a suitable period of time, for example 17 hours, the cup is removed from the oven and allowed to cool for 20 minutes to reach room temperature. After reweighing,the maεε of water loεt by vapour tranεmisεion iε calculated. The moisture vapour permeability iε expressed in unit of gm -2 24 hrε-1 at
37°C, 100% to 10% relative humidity difference, that iε it iε the maεε of water transmitted through a square metre of material in a 24 hour period when maintained at 37°C and there are differences of relative humidity at the two surfaces of the material at 100% inside the cup and 10% outside. This iε the moisture vapour transmission rate when the film or dressing is in contact with moisture vapour. The moiεrure vapour transmiεsion rate when the adhesive is in contact with water may be measured using the same apparatus. When - 12 - the cup iε placed in the oven the cup iε inverted εo that liquid water (and not moisture vapcur) iε in contact with the teεt material.
In a modification of the invention the εubεtrate could be formed from knitted or woven polymers to form a tight web of εmall mesh εize. After cell culture the web centre can be stretched to form a web having a larger mesh size without loss of cellε.
In a further modification still the subεtrate could comprise two interlocking nets such that the apertureε in one net correspond to the strand portions of the other net. The two netε could then be peeled apart poεt-culture and since both would carry cells they could both be applied to the patient.
Suitable corona-discharge treated polymeric filmε may have a thickneεε not exceeding 0.075mm, a water uptake not exceeding 15%, a percentage reduction in cell growth of not more than 50%, a cytotoxicity of not more than 30% and a moisture vapour permeability not exceeding 2500gm -2 24hrε-1
The polymerε employed in the preεent invention are εynthetic and do not comprise any naturally occuring polymeric materials or residues. Such synthetic polymerε can therefore be produced to a high degree of conformity and conεiεtency. Suitable polymerε having for uεe in the manufacture of the εubstrates employed in the dressings of invention include copolymerε, block copoly ers and polymer blends.
Apt copolymerε are thoεe containing vinyl acetate reεidueε such aε the ethylene-vinyl acetate copolymerε. Suitable ethylene-vinyl acetate copolymerε are those containing not more than 20% vinyl acetate. A preferred material, known aε EVA 538/539 containε 16% vinyl acetate.
Other εuitable polymerε include essentially hydrocarbon based materials such as the polybutadienes, polypropylene and polystyrene. Preferred grades of polystyrene include the high impact polystyrenes such as that sold under the trade name STYRON.
Suitable polymerε for uεe in the invention may include block copolymerε having hard end blocks and softer mid blocks. Apt block copolymerε include styrene based rubbers such aε εtyrene-butadiene-εtyrene (manufactured by Shell Chemical Co under the trade name CARIFLEX or KRATO ) .
Another claεs of polymers suitable for the purposes of the invention are polyeεterε. A suitable member of this claεε iε polyethylene pterephthalate (manufactured and εold by ICI under the trade name MELINEX).
Polymer blendε may alεo be employed for the εubεtrateε of the invention. Preferred materialε are blends of ethylene-vinyl acetate with hydrocarbons such aε a polyolefin or an aromatic hydrocarbon. A preferred material iε a blend of 90% EVA and 10% high impact polyεtyrene.
Preferably the polymeric film subεtrate should desirably be transparent in order to allow visualisation of the wound through the dresεing.
It iε preferred to use autologous cultivated epithelial cells since these have little or no imsunological rejection problems when applied to the host (patient). Preferably the cells are keratinocyteε. We have found that it iε deεirable not to allow the cell layer to reach confluence before tranεferring the wound dreεεing onto the wound εite. Aptly the cellε εhould have reached at leaεt 30% confluence before tranεfer, favourably at leaεt 40% and preferably at leaεt 50%. It iε poεεible that a εuitable wound dressing could be produced within a few hours making the dressing particularly suitable for use as an emergency field dreεεing when rapid treatment is required.
Preferably the dresεing compriεeε a cell layer which iε not more than 2 cells thick, more preferably the cell layer iε a monolayer.
The polymeric film substrates can be εteriliεed by either ethylene oxide (allowing the required time for de-gaεεing) or by gamma-irradiation. It iε important that the polymeric filmε are waεhed to remove any low molecular weight contaminants, for example unpolymerised monomer. Such monomers can be cytotoxic and for the reasons given above the substrate should be subεtantially non-cytotoxic. The waεhing proceεε may comprise several sequential washes using sterile de-ionised water in sequential εtepε.
In the system of the invention the substrate on which the cellε are grown εhould preferably be easily removable from the other parts of the system, namely the means for maintaining the aqueous culture medium containing said cellε in contact with one εurface of the film. For example, where the εubεtrate forms one of the walls of the vessel containing the culture medium, it should be readily removable from the other parts of the vessel. The polymeric film substrate may form a part or all of the container in which the cell culture iε grown. The other partε of the container or culture veεsel may be formed from suitable materials conventionally used for the manufacture of tiεεue culture veεεelε. High impact polystyrene is preferred.
In an alternative embodiment the εubεtrate may be laid down within a flask of an appropriate design adapted to allow the removal of the subεtrate.
Where the εubεtrate is an integral part of the culture flask it may be removably sealed to the other parts of the flask for example by heat sealing or by meanε of an adhesive. Preferably the subεtrate will form a flat εurface and will aptly form the wall of the flask.
Where the subεtrate is to be contained within the flask, the flask will be provided with a closeable opening having dimensions sufficient to enable the subεtrate to be readily removed without disruption of the cells anchored thereto.
Where apertured εubεtrateε which are used to form an integral part of the culture flask these may be overlain by continuous film to keep the vessel water tight and to maintain sterility. If the substrate is laid down within the flask or vessel it may be retained by, for example, a pre-sterilised stainless steel ring or, alternatively, by coating the subεtrate on one εide - 17 - with a layer of non-cytotoxic adheεive which iε capable of maintaining tack in the presence of tissue culture medium.
Nutrients, growth factors or medicaments such as antibiotics or antiflammatories may be incorporated into the aqueous medium in which the cell culture iε grown. The nature and weight and/or volume of such additional ingredients are conventionally well known.
The wound dressing of this invention is particularly suitable for treating partial-thickness wounds that iε thoεe where only the epidermiε and poεεibly part of the dermis is loεt. Such wounds include for example skin graft donor siteε, first or posεibly second degree burns, shallow leg ulcers or pressure sores. Continuous polymeric film subεtrate aptly act aε barrierε to bacteria whilst being sufficiently permeable to moiεture vapour, oxygen and carbon dioxide to allow wound healing to occur at a desirable rate. If the εubεtrate iε perforated, a εecondary dressing could be applied to maintain the desired degrees of moisture vapour, oxygen and carbon dioxide permeabilities. A suitable material is a polyurethane film dressing such aε OPSITE (Trade Mark) to create the εame conditionε. The dressing can suitably be left in place on the wound for a period of up to 7 days allow the wound to become from 30-90% re-epithelialiεed (healed) depending on the nature of the particular wound and the condition of the patient. At thiε time the dreεεing can be removed and replaced with conventional wound dressings.
The dresεingε of the preεent invention offer many advantageε ovr prior art arrangementε. Hitherto it haε been neceεεary to culture the layerε to a thickneεε of εeveral cellε in order for the cell layer to be handled and manipulated. It waε alεo neceεεary to grow cell layerε to a larger area than required for the dresεing since during the conventional enzymatic harvesting techniques the sheet tended to shrink. In addition to the time required to produce a cell εheet which waε both large enough to cover the wound and εtrong enough to be handled, there are additional diεadvantages to the use of multi-layer cell sheets. In order to obtain rapid assimilation of the donor sheet into the wound it iε highly deεirable that the baεal εurface (which contains actively growing cells) of the cell sheet be in contact with the wound surface. During manipulation of known multi layer cell sheets it is possible for the non-basal layer (where the cells are terminally differentiated) to be the surface in contact with the wound. With the dreεεingε of the invention it iε not necessary, or even desirable to achieve confluence. The dressings of the present invention which comprise a sub-confluent monolayer of cells can be readily produced in a matter of hours, can be readily handled and when presented to the wound will bring actively growing basal cells directly into contact with the host (patient) substrate.
In addition to the foregoing advantages the systemε of the invention may utilise cell feed techniques without the disadvantages hitherto associated with these techniques.
In 1975 Green et al proposed the use of transformed cell line 3T3 cells derived from the mouse as a feeder layer syεtem in order to expand εkin cultureε. 3T3 cellε synthesized factors which were essential for the growth of keratinocytes which were εeeded at very low denεititeε and 3T3 cellε inhibit fibroblaεt growth, which are unwanted in skin cell preparation. Skin cell preparation containing 3T3 cells first have to be γ-irradiated (typically about 6000 rads) to inhibit cell division yet not kill the cells. Such cells will survive for several days and during that time will synthesize and supply materials for the host keratinocyte cells. Eventually the 3T3 cells are expelled for the εkin cell layer, but inevitably εome mouεe cellε remain and will be grafted with the other hoεt keratinocyteε.
In the dreεεings of the present invention the feeder cells such as 3T3 may be εeeded into a medium in contact with the reverse side of the substrate. These cellε will then εyntheεize materialε for the host cells. Since the feeder cells do not come into contact with the host cells there iε no need to irradiate them. When the εubεtrate is removed from the culture falεk the reverse side may be washed to reverse the free floating feeder cells.
Where a feeder cell layer is employed with an apertured εubεtrate the apertureε εhould be large enough to allow free exchange of the culture media but not large enough to allow cellε to paεs through. Aptly the aperture size should not be larger than Sμ acroεε itε largest dimenions. Suitably the aperture εize will be from 0.5 - 2μ .
Embodimentε of the dreεεing εystems of the invention will be illustrated by reference to the accompanying drawings. Refering to Figure 1, one wall of a culture flask 1 compriseε a laminate of an apertured film 2 upon a confcinuouε carrier layer 3. The edgeε of the carrier layer are removably bonded to the other wall portions 5 of the flask 3. Culture media 4 and donor cellε can be introduced into flask 3 through neck 6 and sealed therein by stopper 7.
After cell culture, the laminate 2, 3 can be removed by peeling from flask 1. An apertured dreεεing compriεing cellε anchored to εheet 2 can be separated from the carrier layer 3 and applied to a patient.
In figure 2, the laminate 2, 3 is formed by casting the εubεtrate film 2 over a carrier layer 3 being a plurality of raiεed portions 8. The cast substrate layer 2 has a plurality of thin 9 and thickened 10 areas. When the substrate is separated from the carrier layer, the thin areaε 9 rupture to form apertureε 12 aε shown in Figure 3.
Referring to Figure 4, the culture flaεk 1 iε divided into compartments 21, 31 by a perforated film 2 comprising the substrate. Nutrient media 4 is introduced into the flask and occupies both compartments 21, 31. Skin cells are εeeded into compartment 21 through neck 6 whilεt feeder cellε εuch aε 3T3 cells are seeded into compartment 31 through access port 11. After the layer of εkin cellε 11 haε reached the required degree of confluence it iε detached from the wall portion 5 of the flaεk and removed from the acceεε port 13.
Nutrients, growth factors or medicaments εuch aε antibioticε or antiinfla matorieε may be incorporated into the aqueous medium in which the cell culture is grown. The nature of weight and/or volume of εuch additional ingredientε are conventionally well known.
The invention will now be illuεtrated by the following Exa pleε wherein the contact angle, cell growth reduction and cytotoxicity were determined aε followε:
Measurement, of contact angleε - surface energy determination
Contact angleε are meaεured uεing a contact angle goniometer aε follows:
Each film subεtrate iε layed flat on the goniometer εtage. The two contact solutions used are distilled water, dekalin and glycerol. The micrometer screw syringe is filled with distilled water and one drop is allowed to contact the film surface to be measured. At time - 0 a photograph of the droplet shape is taken via a camera mounted to the eyepiece of the goniometer. Further photographs are taken periodically (every minute) for approximately ten minutes. The procedure iε then repeated uεing glycerol and dekalin aε the contacting medium.
The reεultant photographs are then developed. The angle the droplet makes to the horizontal is then meaεured uεing a protractor (meaεured both sides).
Graphε of contact angle versus time are then plotted and the angle at time - 0 determined according to the following formula:
surface tension of a liquid « surface free energy (Y) Total surface energy (γ) « + γp γ - dispersive component γP - polar component
1 + Cosθ - 2[(γ*( { <Y Ϊ|]
Figure imgf000025_0001
Yl
A method for measuring percentage cell growth reduction
Human epithelial cells (keratinocytes) are seeded onto a substrate or tisεue culture plate at a density of 8 x
10 5 or 1.5 x 105 respectively per well in 6 well plates. Cells are cultured in 3mlε of the appropriate media containing 10% foetal calf εerum and incubated at
37 C until they reach approximately 50% confluence.
The culture media iε then aεpirated and the cellε re-fed with 3mlε of media containing 0.66 Ci ml"
(εpecific activity 5.0 Cimmol"" ) of tritiated thymidine εupplied by Amerεham International pic. After 18 hours incubation, the media iε again aεpirated and the εubstrateε removed from their wells. The εubεtrateε are then washed extensively with phosphate buffered saline to remove excess tritiated thymidine. The subεtrateε are extracted and then the radioactivity preεent in trichloroacetic acid insoluble precipitate iε measured in a liquid scintillation counter.
The results are expressed as a percentage reduction in tritiated thymidine uptake compared to values obtained in control wells containing no subεtrate.
A method for meaεuring percentage cellular cytotoxicity of the εubεtrateε
1. Collection of εubεtrate supernatants
Each substrate is εet up in duplicate in a 6 well culture plate containing 5mlε of either εerum free media or media containing 10% foetal calf εerum. After one week'ε incubation at 37°C the "substrate supernatants" are collected and frozen at -20°C until required.
2. Cytotoxicity Asεay
Human epithelial cellε are εeeded at a density of 2 x
4 10 cells per well (100 1 volume) into a 96 well culture plate, and incubated at 37°C until the cellε reach confluence. The culture media is then aspirated and media containing 10 Ci ml -1 of 51Cr aqueous sodium dichro ate added to the cells. After 24 hours further incubation, the media is aspirated and the cellε waεhed three timeε with calcium-magneεium free Hankε Balanced
Salt Solution to remove exceεε Cr not taken up by viable cellε. Each "Substrate Supernatant" iε added to each of four wells in either serum free media or media containing 10% foetal calf serum. 10% foetal calf serum is also added to substrate supernatants which were previously incubated in serum free media. After
24 hours incubation at 37 C the supernatants are collected and Cr released from dead or damaged cells is measured in a gamma counter.
51 Baseline measurement of release of Cr from viable cellε iε meaεured in εerum free media and media containing 10% εerum and maximum releaεe of Cr from cellε lapεed in 1% sodium dodecyl sulphate. The percentage cellular cytoxicity iε meaεured according to the following formula:
%Cytotoxicity -
Experimental releaεe - baseline releaεe x 100
Maximum releaεe - baεeline releaεe
Example 1
Human Epithelial cellε (keratinocyteε) were cultured to 50% confluence onto corona-diεcharge treated discε of 15 cm x 12 cm MELINEX film 23// thick.
Corona diεcharge waε carried out on the film substrate prior to culture using a Sherman C-treater. The C-treater waε used manually and set to deliver greater than 50 dynes/cm to the εubεtrate surface. The subεtrate iε placed under the head of the machine and removed slowly in order to achieve this level of treatment.
The culture medium uεed waε baεed on Green'ε method aε εtated in Barlow & Pye (1990) Methods in Molecular Biology Chapter 5 (Humana Presε). It consisted of 3 parts DMEM: 1 part F12 containing 10% foetal calf serum and EGF (10 ng ml" ), insulin (5 /g ml" ), hydrocortisone (0.2 μg ml -1), cholera toxin (10-9M),
—1 —8 tranεferrin/triiodothyronine ( 5 g ml ), (2 x 10 M) and adenine (1.8 x 10 -4M) final concentration.
Alternative but equally acceptable media include Keratinocyte Basal Media available from Clonetics & BIORICH Media available from Flow Laboratories. Both of these media are εerum free.
The percentage cell growth reduction was found to be 28%.
The percentage cellular cytotoxicity was found to be 7%.
Example 2
Example 1 waε repeated uεing corona-discharge treated ethyl vinyl acetate film at 15// thickneεε (EVA 538/539).
The percentage cell growth reduction was found to be 41.5%.
The percentage cellular cytotoxicity was found to be 0%. The contact angle waε found to be 78° on untreated film and 55.5° on corona-diεcharge treated film.
Example 3
Example 1 waε repeated uεing corona-diεcharge treated polyiεobutadiene film at 20// thicknesε.
The percentage cell growth reduction was found to be 33%.
The percentage cellular cytotoxicity was found to be 1%.
The contact angle was found to be 98° on untreated film and 79.5% on corona-diεcharge treated film.
Example 4
Example 1 waε repeated using corona-diεcharge treated ethyl vinyl acetate/high impact polyεtyrene blends at 20/ thicknesε. The following blendε gave the reεultε εhown. EVA(28-05)/HIPS 80:20 23% cell growth reduction and
13% cellular cytotoxicity EVA539/HIPS 90:10 8% cell growth reduction and
29% cellular cytotoxicity
Example 5
Example 1 was repeated uεing corona-discharge treated polypropylene film at 20// thickneεε.
The percentage cell growth reduction waε found to be 47%.
The percentage cellular cytotoxicity was found to be 8%.
Example 6
Example 1 was repeated uεing corona-discharge treated high impact polyεtyrene film (STYRON) at 20// thickneεε.
The percentage cell growth reduction was found to be 32%.
The percentage cellular cytotoxicity was found to be 8% .
Example 7
Example 1 was repeated using corona-discharge treated styrene-butadiene-styrene rubber film (CARIFLEX 1101) at 20// thicknesε.
The percentage cell growth reduction waε found to be 41.5%.
The percentage cellular cytotoxicity waε found to be 1%.
Example 8
Example 1 waε repeated using corona-discharge treated polyvinylidene chloride (PVDC) film at 20// thickneεε.
The percentage cell growth reduction waε found to be 27%.
The percentage cellular cytotoxicity was found to be 25%. Exampleε 9 - 16
Exampleε 1 - 8 were repeated but the filmε were perforated prior to culture uεing hot-pin perforation techniqueε to give an open area of 25%. Good cell growth waε achieved in all caεeε with minimal cell loss or perforation.
Exampleε 17 - 24
A system according to Figure 1 waε uεed to produce a wound dresεing. The pre-perforated films used were thoεe aε deεcribed in Exampleε 9 - 16. The cells were grown to 20% confluence (approximately 24-36 hourε). The carrier (2) and perforated substrate carrying the cells (1) was detached from the culture vesεel (3) and the εubεtrate waε then peeled from the carrier. Good cell growth waε achieved in all caεes.
Examples 25 - 32
Exampleε 17 - 24 were repeated but instead of pre-perforating the films they were cast onto the base of a flaεk containing 1mm stumps according to Figure 2, After culture the substrate was peeled from the base according to Figure 3 and was successfully perforated aε well aε achieving good cell growth in all caεeε. Cell loεε waε minimal.
Example 33
Example 4 waε repeated and the εubstrate was perforated by stretching according to the method described in European Patent No 0141592. Good cell growth waε achieved with no loεε of cellε upon perforation.
Example 34
Example 20 waε repeated but the εubεtrate waε not pre-perforated. Inεtead it waε εtretched according to Example 33 and εpontaneouεly perforated. Good cell growth waε achieved with no loss of cellε upon perforation.
Example 35
A εyεtem according to Figure 1 waε uεed to produce a wound dreεεing. The net used was as described in PCT Publication No GB090/00398. The cells were grown for approximately 24 hours and the carrier (3) and net (2) carrying the cells were detached from the culture vesεel (5). The net was then peeled from the carrier and good cell growth was observed on the net. - 33 -
Example 36
Example 35 waε repeated but two sheets of the net were aligned such that the apertureε of one net coincided with the continuouε portions of the other net. The whole waε then sealed to the bottom of the culture veεεel (5) and the cellε cultured aε before. Upon removal from the veεεel after 24 hourε the two netε were εeparated and both εhowed good cell growth. Both netε were then tranεferred to a patient succeεεfully. Good heating rateε and goods host compatibility were observed.
Example 37
Exampleε 1 and 2 were repeated and the resultant dresεingε were uεed εimultaneouεly in the treatment of a 3 year old female burnε patient. The patient waε burned to approximately 40% of body surface area covering the head, one arm, one leg and one εide of her body. The patient waε grafted on four separate occaεions using a combination of split skin grafting and the wound dressing containing the culture cells. The cell culture was derived from an autologous biopsy taken during debridement of the burns patient. The initial seeding denεity waε between 2.5 x 10 and 6 x 104 cells per cm2. The culture waε grafted approximately 80 hourε after the cellε were εeeded.
The εubεtrate film waε covered with a secondary dresεing comprising a liquid paraffin tulle gras
JELONET (Trade Mark) which in turn waε covered with crepe bandaging. After 5 dayε the secondary dresεingε were removed, the substrate films fell-off with no noticeable adherency and no cells remained on the film.
The wounds beneath had healed. No significant difference was obεerved between the two types of dresεing.

Claims

- 35 - CLAIMS
1. A conformable wound dreεεing compriεing a layer of cultured mammalian cells anchored to one surface of a subεtrate compriεing a film of εynthetic polymer and which εubεtrate iε hydrophobic, non-inhibiting to cell growth and non-cytotoxic.
2. A dreεεing according to claim 1 wherein the cellε are epithelial cells.
3. A dreεεing according to claim 1 or claim 2 wherein the cell layer iε a εub-confluent layer.
4. A dreεεing according to claim 3 wherein the degree of confluence is from 40 to 70%.
5. A dressing according to any one of the preceding claims wherein the cell layer iε a mono-layer.
6. A dreεεing according to any one of the preceding claims wherein the substrate is moisture vapour permeable.
,
7. A dressing according to any one the previous claims wherein the substrate comprises a continuouε film of polymer material.
8. A dressing according to claim 7 wherein the film is adapted to be perforated.
9. A dresεing to claim 8 wherein the film haε weakened areaε which upon εtretching will rupture to form apertureε.
10. A dreεεing according to any one of claimε 1 to 6 wherein the film iε an apertured film.
11. A modification of the dreεεing according to any of claims 1 to 6 wherein the subεtrate comprises a net of said synthetic polymer material.
12. A dressing according to claim 11 wherein the net is a knitted or woven fabric.
13. A dresεing according to any one of the preceding claimε wherein the εubεtrate compriεeε a corona discharge treated polymer.
14. A dressing according to any one of the preceding claims in which the polymer is an ethylene-vinyl acetate copolymer.
15. A dreεεing according to claim 14 in which the polymer iε a blend of an ethylene-vinyl acetate copolymer and a polystyrene.
16. A εyεtem for the manufacture of wound dreεsings comprising a substrate for culturing anchorage dependent mammalian cells and means for maintaining a culture medium in contact with εaid εubεtrate wherein said substrate is a conformable film of a synthetic polymeric material and iε hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
17. A system according to claim 16 wherein the subεtrate formε part of the meanε for containing the culture medium.
18. A system according to claim 16 or claim 17 wherein the subεtrate compriεeε a continuouε polymer film.
19. A εyεtem according to claim 18 wherein the εubstrate is adapted to be perforated. - 38 -
20. A syεtem according to claim 19 wherein the εubεtrate iε a biaxially oriented film.
21. A εyεtem according to claim 16 wherein the εubεtrate iε an apertured film.
22. A modification of the system according to claim 16 wherein the εubstrate comprises a net of said synthetic polymer material.
23. A dresεing according to any one of claimε 17, 21 or 22 wherein the substrate is releasably supported on a liquid impervious carrier layer which formε part of the containing means.
24. A εyεtem according to claim 23 wherein εaid carrier layer iε provided with a plurality of raiεed projectionε and said substrate has a plurality of thinner areaε corresponding to the areaε of the projection of the carrier layer.
25. A εyεtem according to claim 24 wherein the εubεtrate iε caεt onto the carrier layer.
26. A εyεtem according to any one of claims 16 to 22 wherein the subεtrate iε arranged and supported within the containing means thereby to allow contact of the culture medium to opposed sides of the subεtrate.
27. A εyεtem according to claim 26 wherein the containing meanε haε εeparate meanε of acceεε to both εides of the εubεtrate.
28. A εystem according to any one of claims 16 to 27 wherein the substrate has been subjected to a corona diεcharge treatment.
29. A εyεtem according to any one of claimε 16 to 28 wherein the εynthetic polymer iε an ethylene-vinyl acetate copolymer.
30. A εyεtem according to claim 29 where the polymer iε a blend of ethylene-vinyl acetate copolymer and a polystyrene.
31. A method for the _in vitro cultivation of anchorage dependent mammalian cells which compriseε containing a εubstrate with a culture medium comprising anchorage dependent mammalian cellε wherein εaid εubstrate compriεes a film of εynthetic polymer material and which iε hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
32. A method according to claim 31 wherein the εubεtrate iε a continuouε film.
33. A method according to either claim 31 or 32 wherein the εubεtrate iε adapted to be perforated.
34. A method according to claim 31 wherein the substrate iε an apertured film.
35. A modification of the method according to claim 31 or 34 wherein the substrate compriεeε a net of εaid εynthetic polymer material.
36. A method according to any one of claimε 31 to 35 wherein the εubεtrate iε a corona diεcharge treated polymer material.
37. A method according to any one of claimε 31 to 36 wherein the synethetic polymer is a ethylene-vinyl acetate copolymer.
38. A method according to claim 37 wherein the polymer iε a blend of ethylene-vinyl acetate copolymer and a polyεtyrene.
39. A method for the treatment of woundε which compriεeε forming a dreεsing by contacting a εubεtrate with a culture containing anchorage dependent mammalian cellε to form an anchored cell layer on εaid εubstrate and applying εaid dresεing to a wound whereby said cell layer in contact with the wound and wherein the εubstrate compriεeε a film of synthetic polymer material and is hydrophobic, non-inhibitory to cell growth and non-cytotoxic.
40. A method according to claim 39 wherein said dressing is produced in a system as described in any one of claimε 16 to 30 or by the method claimed in any one of claimε 31 to 38.
PCT/GB1991/000329 1990-03-05 1991-03-04 Cell culture products WO1991013638A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP91905276A EP0518920B1 (en) 1990-03-05 1991-03-04 Cell culture products
DE69120527T DE69120527T2 (en) 1990-03-05 1991-03-04 CELL CULTURE PRODUCTS
AU73485/91A AU649656B2 (en) 1990-03-05 1991-03-04 Cell culture products
GB9205228A GB2252562B (en) 1990-03-05 1992-03-11 Wound dressing comprising cultured cells
US09/009,673 US6039972A (en) 1990-03-05 1998-01-20 Wound dressing containing mammalian cells anchored on hydrophobic synthetic polymer film

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9004911.5 1990-03-05
GB909004911A GB9004911D0 (en) 1990-03-05 1990-03-05 Cell culture products

Publications (1)

Publication Number Publication Date
WO1991013638A1 true WO1991013638A1 (en) 1991-09-19

Family

ID=10672028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/000329 WO1991013638A1 (en) 1990-03-05 1991-03-04 Cell culture products

Country Status (11)

Country Link
EP (2) EP0681846A3 (en)
JP (1) JPH05504497A (en)
AT (1) ATE139685T1 (en)
AU (1) AU649656B2 (en)
CA (1) CA2065432A1 (en)
DE (1) DE69120527T2 (en)
DK (1) DK0518920T3 (en)
ES (1) ES2089195T3 (en)
GB (2) GB9004911D0 (en)
WO (1) WO1991013638A1 (en)
ZA (1) ZA911598B (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648264A1 (en) * 1992-06-03 1995-04-19 Case Western Reserve University Bandage for continuous application of biologicals
EP0681846A2 (en) 1990-03-05 1995-11-15 Smith & Nephew P.L.C. Cell culture products
WO1996003094A1 (en) * 1994-07-25 1996-02-08 W.L. Gore & Associates Gmbh Membrane for regenerating body tissues and use of said membrane as a wound covering and substitute skin
EP0747475A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0747474A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0747473A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0755261A1 (en) * 1993-06-02 1997-01-29 Case Western Reserve University Bandage for continuous application of biologicals
WO1997006835A1 (en) * 1995-08-12 1997-02-27 Smith & Nephew Plc Cell culture products
WO1997026023A1 (en) * 1996-01-19 1997-07-24 Eth, Eidgenössische Technische Hochschule Zürich Wound dressing and apparatus
WO1998013076A1 (en) * 1996-09-24 1998-04-02 Brigham And Women's Hospital Cultured cell-seeded fibrous lattice for tissue replacement
WO1998024880A1 (en) * 1996-12-05 1998-06-11 Smith & Nephew, Plc Cell-culture system
WO1998027195A1 (en) * 1996-12-18 1998-06-25 Roche Diagnostics Gmbh Receptacle for cell cultures and use of multiple dishes for culturing antitumour cells
WO1999037336A2 (en) * 1998-01-21 1999-07-29 Nitto Denko Corporation Substrate for adhesive dressing
EP1020196A1 (en) * 1999-01-14 2000-07-19 Nitto Denko Corporation Medical adhesive dressing and first-aid adhesive tape
US6210704B1 (en) 1999-01-14 2001-04-03 Nitto Denko Corporation Medical adhesive dressing and first-aid adhesive tape
WO2008060822A2 (en) * 2006-10-20 2008-05-22 Keracure, Inc. Devices with cells cultured on flexible supports
WO2010135915A1 (en) 2009-05-27 2010-12-02 上海交通大学 Use of midkine and medical device containing midkine
WO2013174769A1 (en) 2012-05-25 2013-11-28 Boehringer Ingelheim International Gmbh Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5866983B2 (en) * 2011-11-08 2016-02-24 大日本印刷株式会社 Cell culture vessel
KR101335176B1 (en) * 2011-12-12 2013-11-29 테고사이언스 (주) Wound Dressing
US9790465B2 (en) 2013-04-30 2017-10-17 Corning Incorporated Spheroid cell culture well article and methods thereof
JP6930914B2 (en) 2014-10-29 2021-09-01 コーニング インコーポレイテッド Perfusion bioreactor platform
SG11201703493SA (en) 2014-10-29 2017-05-30 Corning Inc Cell culture insert
US11857970B2 (en) 2017-07-14 2024-01-02 Corning Incorporated Cell culture vessel
JP7195302B2 (en) 2017-07-14 2022-12-23 コーニング インコーポレイテッド Cell culture vessel for 3D culture and method for culturing 3D cells
WO2019014636A1 (en) 2017-07-14 2019-01-17 Corning Incorporated Cell culture vessel
EP3652290B1 (en) 2017-07-14 2022-05-04 Corning Incorporated 3d cell culture vessels for manual or automatic media exchange
CN111032851B (en) 2018-07-13 2024-03-29 康宁股份有限公司 Microcavity dish having a sidewall with a liquid medium transfer surface
JP7171696B2 (en) 2018-07-13 2022-11-15 コーニング インコーポレイテッド Fluidic device comprising a microplate with interconnected wells
EP3649229B1 (en) * 2018-07-13 2021-08-25 Corning Incorporated Cell culture vessels with stabilizer devices

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092302A2 (en) * 1982-04-16 1983-10-26 Becton Dickinson and Company Chemically specific surfaces for influencing cell activity during culture
WO1988008448A2 (en) * 1987-04-22 1988-11-03 Michael Bay Cell culture processes, materials and products
WO1989003228A1 (en) * 1987-10-14 1989-04-20 Board Of Regents, The University Of Texas System Epidermal graft system
WO1990000595A1 (en) * 1988-07-05 1990-01-25 Banes Albert J Floating cell culture device and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL267226A (en) 1960-07-19
GB1055963A (en) 1963-08-27 1967-01-25 Smith & Nephew Improvements in and relating to open work materials in sheet form
GB8328279D0 (en) 1983-10-22 1983-11-23 Smith & Nephew Res Polymer blend films
IL75554A (en) * 1985-06-18 1993-01-14 Yeda Res & Dev Matrix for cell cultivation in vitro
DE289666T1 (en) * 1987-04-03 1989-08-03 Yeda Research And Development Co., Ltd., Rehovot Cell culture carrier.
CA1315491C (en) 1989-06-28 1993-04-06 Desmond Maurice Kendall Sanitary fixtures
GB9004911D0 (en) 1990-03-05 1990-05-02 Smith & Nephew Cell culture products

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092302A2 (en) * 1982-04-16 1983-10-26 Becton Dickinson and Company Chemically specific surfaces for influencing cell activity during culture
WO1988008448A2 (en) * 1987-04-22 1988-11-03 Michael Bay Cell culture processes, materials and products
WO1989003228A1 (en) * 1987-10-14 1989-04-20 Board Of Regents, The University Of Texas System Epidermal graft system
WO1990000595A1 (en) * 1988-07-05 1990-01-25 Banes Albert J Floating cell culture device and method

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0681846A2 (en) 1990-03-05 1995-11-15 Smith & Nephew P.L.C. Cell culture products
EP0648264A1 (en) * 1992-06-03 1995-04-19 Case Western Reserve University Bandage for continuous application of biologicals
EP0648264A4 (en) * 1992-06-03 1997-10-01 Univ Case Western Reserve Bandage for continuous application of biologicals.
EP0755261A1 (en) * 1993-06-02 1997-01-29 Case Western Reserve University Bandage for continuous application of biologicals
EP0755261A4 (en) * 1993-06-02 1997-06-25 Univ Case Western Reserve Bandage for continuous application of biologicals
WO1996003094A1 (en) * 1994-07-25 1996-02-08 W.L. Gore & Associates Gmbh Membrane for regenerating body tissues and use of said membrane as a wound covering and substitute skin
EP0747474A3 (en) * 1995-06-06 1998-06-03 Becton, Dickinson and Company Culture slide assembly
EP0747473A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0747474A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0747475A2 (en) * 1995-06-06 1996-12-11 Becton, Dickinson and Company Culture slide assembly
EP0747473A3 (en) * 1995-06-06 1998-06-03 Becton, Dickinson and Company Culture slide assembly
EP0747475A3 (en) * 1995-06-06 1998-06-03 Becton, Dickinson and Company Culture slide assembly
WO1997006835A1 (en) * 1995-08-12 1997-02-27 Smith & Nephew Plc Cell culture products
WO1997026023A1 (en) * 1996-01-19 1997-07-24 Eth, Eidgenössische Technische Hochschule Zürich Wound dressing and apparatus
WO1998013076A1 (en) * 1996-09-24 1998-04-02 Brigham And Women's Hospital Cultured cell-seeded fibrous lattice for tissue replacement
GB2334530A (en) * 1996-12-05 1999-08-25 Smith & Nephew Cell-culture system
WO1998024880A1 (en) * 1996-12-05 1998-06-11 Smith & Nephew, Plc Cell-culture system
WO1998027195A1 (en) * 1996-12-18 1998-06-25 Roche Diagnostics Gmbh Receptacle for cell cultures and use of multiple dishes for culturing antitumour cells
WO1999037336A2 (en) * 1998-01-21 1999-07-29 Nitto Denko Corporation Substrate for adhesive dressing
WO1999037336A3 (en) * 1998-01-21 1999-10-28 Nitto Denko Corp Substrate for adhesive dressing
EP1020196A1 (en) * 1999-01-14 2000-07-19 Nitto Denko Corporation Medical adhesive dressing and first-aid adhesive tape
US6210704B1 (en) 1999-01-14 2001-04-03 Nitto Denko Corporation Medical adhesive dressing and first-aid adhesive tape
WO2008060822A2 (en) * 2006-10-20 2008-05-22 Keracure, Inc. Devices with cells cultured on flexible supports
WO2008060822A3 (en) * 2006-10-20 2008-07-24 Keracure Inc Devices with cells cultured on flexible supports
US8658851B2 (en) 2006-10-20 2014-02-25 Keracure, Inc. Devices with cells cultured on flexible supports
WO2010135915A1 (en) 2009-05-27 2010-12-02 上海交通大学 Use of midkine and medical device containing midkine
WO2013174769A1 (en) 2012-05-25 2013-11-28 Boehringer Ingelheim International Gmbh Use of keratinocytes as a biologically active substance in the treatment of wounds, such as diabetic wounds, optionally in combination with a dpp-4 inhibitor

Also Published As

Publication number Publication date
DE69120527T2 (en) 1997-01-16
ES2089195T3 (en) 1996-10-01
DK0518920T3 (en) 1996-08-05
AU649656B2 (en) 1994-06-02
GB9205228D0 (en) 1992-05-27
GB2252562A (en) 1992-08-12
ZA911598B (en) 1991-11-27
GB2252562B (en) 1994-04-20
EP0681846A2 (en) 1995-11-15
CA2065432A1 (en) 1991-09-06
AU7348591A (en) 1991-10-10
EP0518920B1 (en) 1996-06-26
EP0518920A1 (en) 1992-12-23
GB9004911D0 (en) 1990-05-02
EP0681846A3 (en) 1996-03-27
ATE139685T1 (en) 1996-07-15
JPH05504497A (en) 1993-07-15
DE69120527D1 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
WO1991013638A1 (en) Cell culture products
US6039972A (en) Wound dressing containing mammalian cells anchored on hydrophobic synthetic polymer film
US7741116B2 (en) Surgical device for skin therapy or testing
CA2043527C (en) Biocompatible perforated membranes, processes for their preparation, and uses thereof
US4304866A (en) Transplantable sheets of living keratinous tissue
KR940001379B1 (en) Living tissue equivalents
US6040493A (en) Bioreactor wound dressing
US8889417B2 (en) Epidermal cultured cell sheet, multi-layered cultured skin sheet and processes for producing those sheets
US9981064B2 (en) Regenerated corneal endothelial cell sheets, processes for producing the same, and methods of using the same
AU699407B2 (en) Method for long term subculture of dermal papilla cells
JP2003038170A (en) Anterior eye part-associated cell sheet, three- dimensional structure and method for producing them
Ming-liang et al. Microskin grafting. I. Animal experiments
US20060240552A1 (en) Anterior ocular-associated cell sheet, three-dimensional construct and process for producing the same
DE60027724T2 (en) IMPROVED KERATINOCYTE CULTURE AND ITS USES
EP1019104A1 (en) Cell culture products
WO1997026023A1 (en) Wound dressing and apparatus
RU2148970C1 (en) Method for repairing skin cover
WO1990015862A1 (en) In vitro cultivation of epithelial cells
AU3406000A (en) Cell culture products
RU2164940C2 (en) Method of isolation of microalga axenic cultures
Shvets et al. Ability of microautotransplants to re-epithelialize deep and extensive skin injuries
JPH05317406A (en) Artificial skin
Singh et al. The interaction of Geliperm® and cells in culture
IL99548A (en) Composite living skin equivalents and process for their preparation
IE913512A1 (en) Composite living skin equivalents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA GB JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991905276

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2065432

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1991905276

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991905276

Country of ref document: EP